−0.40 USD
−2.90 M USD
0.00 USD
2.02 M
About Liminatus Pharma, Inc.
Sector
Industry
CEO
Chris Kim
Website
Headquarters
La Palma
Founded
2020
FIGI
BBG01HVYG111
Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of LIMN is 5.12 USD — it has decreased by −10.06% in the past 24 hours. Watch Liminatus Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Liminatus Pharma, Inc. stocks are traded under the ticker LIMN.
LIMN stock has fallen by −31.17% compared to the previous week, the month change is a −8.98% fall, over the last year Liminatus Pharma, Inc. has showed a −51.28% decrease.
LIMN reached its all-time high on May 1, 2025 with the price of 16.44 USD, and its all-time low was 5.01 USD and was reached on Apr 28, 2025. View more price dynamics on LIMN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LIMN stock is 18.00% volatile and has beta coefficient of −0.02. Track Liminatus Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Liminatus Pharma, Inc. there?
Today Liminatus Pharma, Inc. has the market capitalization of 32.26 M, it has decreased by −17.09% over the last week.
Yes, you can track Liminatus Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
LIMN net income for the last quarter is −868.31 K USD, while the quarter before that showed −642.90 K USD of net income which accounts for −35.06% change. Track more Liminatus Pharma, Inc. financial stats to get the full picture.
No, LIMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has 3 employees. See our rating of the largest employees — is Liminatus Pharma, Inc. on this list?
Like other stocks, LIMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Liminatus Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Liminatus Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Liminatus Pharma, Inc. stock shows the strong sell signal. See more of Liminatus Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.